Head to Head Contrast: Exactus (OTCMKTS:EXDI) and MariMed (OTCMKTS:MRMD)

Exactus (OTCMKTS:EXDIGet Free Report) and MariMed (OTCMKTS:MRMDGet Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

Profitability

This table compares Exactus and MariMed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Exactus N/A -3,272.69% -185.29%
MariMed -10.97% -2.75% -1.06%

Analyst Recommendations

This is a summary of recent recommendations for Exactus and MariMed, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exactus 0 0 0 0 N/A
MariMed 0 0 0 1 4.00

Valuation and Earnings

This table compares Exactus and MariMed’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Exactus $2.07 million 0.00 -$9.46 million N/A N/A
MariMed $148.60 million 0.42 -$16.03 million ($0.04) -4.14

Exactus has higher earnings, but lower revenue than MariMed.

Risk and Volatility

Exactus has a beta of 4.21, indicating that its stock price is 321% more volatile than the S&P 500. Comparatively, MariMed has a beta of 2.8, indicating that its stock price is 180% more volatile than the S&P 500.

Institutional and Insider Ownership

0.1% of Exactus shares are held by institutional investors. Comparatively, 0.2% of MariMed shares are held by institutional investors. 65.0% of Exactus shares are held by insiders. Comparatively, 20.5% of MariMed shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

MariMed beats Exactus on 6 of the 10 factors compared between the two stocks.

About Exactus

(Get Free Report)

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

About MariMed

(Get Free Report)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Receive News & Ratings for Exactus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactus and related companies with MarketBeat.com's FREE daily email newsletter.